The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 12, 2025

Filed:

Sep. 22, 2021
Applicant:

Roche Diagnostics Operations, Inc., Indianapolis, IN (US);

Inventor:
Assignee:

Roche Diagnostics Operations, Inc., Indianapolis, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/543 (2006.01); A61K 31/16 (2006.01); B01J 20/22 (2006.01); C07C 259/00 (2006.01); C07C 259/04 (2006.01); G01N 1/34 (2006.01); G01N 33/68 (2006.01); G01N 33/92 (2006.01); C07K 5/068 (2006.01); C07K 5/09 (2006.01); C07K 19/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/54326 (2013.01); A61K 31/16 (2013.01); B01J 20/22 (2013.01); B01J 20/223 (2013.01); C07C 259/00 (2013.01); C07C 259/04 (2013.01); G01N 1/34 (2013.01); G01N 33/68 (2013.01); G01N 33/92 (2013.01); C07K 5/06086 (2013.01); C07K 5/0815 (2013.01); C07K 19/00 (2013.01); Y10S 502/507 (2013.01); Y10S 930/28 (2013.01);
Abstract

The present invention relates to a complex comprising a transition metal cation (i); a ligand (ii) comprising at least one chelating group, preferably from 1 to 4 chelating groups, more preferred 2 or 3 chelating groups, wherein the chelating group(s) is/are selected from hydroxamate group —N(O″)—C(═O)—R, catechol ate group, carboxyl ate group, partly or totally protonated forms of these chelating groups and mixtures of these chelating groups and/or their partly or totally protonated forms, wherein R is hydrogen or a C1 to C5 alkyl group; and a magnetic bead (iii); wherein the magnetic bead (iii) and the ligand (ii) are covalently bonded. The invention also relates to the use of the complex for reduction of the content of at least one phosphor-oxy-substance, which preferably comprises a structural element —O—P(O″)(═O)—O— within its structure, in a fluid sample, as well as to a method for decreasing the content of at least one phosphor-oxy-substance, preferably a phospholipid, in a fluid sample, comprising a step of adding the complex. The invention further relates to a supernatant obtained or obtainable from this method and to the use of a supernatant obtained or obtainable from the method for qualitative and/or quantitative determination of at least one analyte in said supernatant. Furthermore, the invention relates to a method for qualitative and/or quantitative determination of at least one analyte in a fluid sample and to a method for determining the kind and/or amount of at least one phosphor-oxy-substance in a fluid sample.


Find Patent Forward Citations

Quick Actions:

Vondenhoff, Gaston Hubertus Maria. (2025). Transition metal chelating beads (U.S. Patent No. 12385907). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12385907

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…